Camena Bioscience is a synthetic biology company that was founded in 2016. The company's technology offers access to long and complex gene sequences, which are normally difficult to produce. Genes are distributed for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors.

New nucleic acid synthesis technology improves the quality and speed of synthesis. Approach of multi-enzymatic technology offers increased accuracy over existing phosphoramidite synthesis methods and unlocks access to complex gene sequences.  The company aims to further enable the engineering of new synthetic biology applications.